ACE BioSciences Overview
- Year Founded
-
2001
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Investors
-
1
ACE BioSciences General Information
Description
Developer of antibacterial drugs. The company is focused on developing novel vaccines for the prevention and treatment of bacterial infections, diarrhea, pneumococcal infections, cancer and streptococcus pneumonia..
Contact Information
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- Unsbjergvej 2A
- 5220 Odense
- Denmark
ACE BioSciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 09-Nov-2009 | 000.00 | Completed | Generating Revenue | ||
| 2. Later Stage VC | 19-Dec-2007 | 000.00 | 000.00 | Completed | Generating Revenue | |
| 1. Early Stage VC | $33.7M | $33.7M | Completed | Startup |
ACE BioSciences Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| BankInvest Biotech Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Dansk Erhvervsinvestering | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Heartcore Capital | Venture Capital | Minority | 000 0000 | 000000 0 |